Article Text

Variability of serum antibody responses of goat kids to a commercial Clostridium perfringens epsilon toxoid vaccine
  1. F. A. Uzal, PhD1,
  2. D. A. V. Bodero, BSc, DipIp2,
  3. W. R. Kelly, PhD1 and
  4. K. Nielsen, PhD3
  1. 1 Division of Veterinary Pathobiology
  2. 2 Division of Fann Animal Studies, School of Veterinary Sciences, Brisbane, Queensland 4072, Australia
  3. 3 Animal Diseases Research Institute, Canadian Food Inspection Agency, Box 11300, Station H, Nepean, Ontario, Canada K2H 8P9


Twenty-nine Angora goats were used in a trial of a commercial enterotoxaemia (pulpy kidney disease) vaccine. The animals were allocated to four groups, of which three received an initial dose of vaccine, two also received a booster of the same vaccine either 28 or 42 days after the first vaccination, and the fourth remained as an unvaccinated control group. An indirect ELISA technique was used to measure the titres of Clostridium perfringens type D epsilon antitoxin in serum samples taken before vaccination and 17, 28, 42, 59, 70, 86, 98 and 128 days after vaccination. There was a wide range of antibody titres after vaccination, and the great majority of the vaccinated animals had titres below the protective level, arbitrarily set at 0.25 iu/ml, by day 98.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.